GGrantIndex
Sort

50,496 grants matching lung cancer

Regulators of Cancer Immunotherapy Response

$604,374
Myles A Brown · Dana-Farber Cancer Inst · R01 · FY2021 · CA

S100A4 Regulation of IPF Mesenchymal Progenitor Cell Fibrogenicity

$604,351
Craig A Henke · University Of Minnesota · R01 · FY2019 · HL

Novel Technology for the Analysis of Gene Expression

$604,343
Ambergen, Inc · R44 · FY2002 · CA

A non-invasive gene-expression biomarker of airway response to tobacco exposure

$604,336
Avrum E Spira · Boston University Medical Campus · U01 · FY2008 · ES

OVERCOMING THE PROTECTIVE BARRIERS OF BREAST CANCER IN BONE MARROW WITH TARGETED PRODRUG NANOTHERAPY

$604,272
Gregory M Lanza · Washington University · R01 · FY2019 · CA

Genetic Determinants of Tumor Growth and Drug Sensitivity in EGFR Mutant Lung Cancer

$604,225
Katerina Abigail Politi · Yale University · R01 · FY2021 · CA

Radon on the RADAR

$604,151
Stacy Stanifer · University Of Kentucky · R01 · FY2024 · ES

Decoding temporal epithelial signaling programs to restore homeostasis in acute lung injury

$604,139
John G. Albeck · University Of California At Davis · R01 · FY2022 · HL

Advanced Imaging for Pulmonary Fibrosis

$604,115
Sydney Montesi · Massachusetts General Hospital · R01 · FY2024 · HL

Epigenetic and immunologic aspects of high-grade neuroendocrine cancers

$604,110
Nitin Roper · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Speckle x-ray imaging: detecting early changes in lung microstructure

$604,050
Peter B Noã‹l · University Of Pennsylvania · R01 · FY2025 · HL

Host control mechanisms against K. pneumoniae infection in the lungs

$603,934
Kong Chen · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL

Cancer Immunotherapy Clinical Trials

$603,896
Christopher Heery · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Development of novel protein-based therapeutics for lung cancer

$603,877
Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2018 · CA

Risk-stratification of Prostate Cancers via Field Carcinogenesis Nanocytology

$603,868
Vadim Backman · Northwestern University · R01 · FY2019 · CA

Lung Adenocarcinoma Invasion Genomics

$603,855
Charles A. Powell · Icahn School Of Medicine At Mount Sinai · R01 · FY2013 · CA

TRAINING IN LUNG SCIENCE

$603,834
David H Ingbar · University Of Minnesota · T32 · FY2011 · HL

COSMOS Eye: Cataract and AMD in a Trial of a Multivitamin and Cocoa Extract

$603,823
Howard D Sesso · Brigham And Women'S Hospital · R01 · FY2020 · EY

Mechanisms of Durable Antitumor Immunity Mediated by PI3K-targeted T cells

$603,809
Chrystal Mary Paulos · Emory University · R01 · FY2024 · CA

Integrated Informatic and Experimental Evaluations of Cancer Chronotherapy

$603,777
Ron C. Anafi · University Of Pennsylvania · R01 · FY2022 · CA

Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA

$603,742
Douglas C Wallace · Children'S Hosp Of Philadelphia · R01 · FY2024 · CA

Discovery and development of Ku-targeted small molecule inhibitors: A novel mechanism of DNA-PK inhibition

$603,569
John J Turchi · Indiana University Indianapolis · R01 · FY2020 · CA

Validation and Translation of MasSpec Pen Technology for Intraoperative Evaluation of Non-small Cell Lung Cancer

$603,561
Livia Schiavinato Eberlin · Baylor College Of Medicine · R01 · FY2025 · CA

Sleep Apnea in Survivors of Childhood Cancer Treated with Thoracic Radiation (APNEA

$603,556
Kevin R Krull · St. Jude Children'S Research Hospital · R01 · FY2020 · CA

Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance

$603,529
Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2020 · CA